# Cannabis and Anxiety Risk Long Term: New Insights 2026 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-anxiety-risk-long-term-march-03-2026/ > **Published:** 2026-03-03T11:41:24-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:12:57-04:00 > **Clinical Summary:** Explore new research on cannabis and anxiety risk long term, highlighting cohort data and clinical insights for 2026. --- Last 24 Hours March 03, 2026 — 1 articles reviewed Today’s feed centers on a single but important theme: the longitudinal relationship between regular [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and anxiety outcomes. New cohort data challenges the popular narrative that cannabis is a reliable long-term solution for [anxiety management](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/). Short-term relief is real, but it is not the whole story. When we prescribe or counsel around cannabis for anxiety, we owe patients an honest conversation about what a decade of data now tells us about sustained use in vulnerable populations. Browse all recent articles at [cedclinic.com/category/cannabis-news/](https://cedclinic.com/category/cannabis-news/) Digest-Level Clinical Commentary Dr. Caplan’s Take Clinical Reflection As someone who counsels patients daily about cannabis for anxiety, this emerging cohort data reinforces what I’m increasingly observing in my practice: that while cannabinoids may provide acute symptom relief, regular use often fails to deliver sustained anxiolytic benefits and may paradoxically worsen anxiety trajectories over time. This distinction between short-term symptom management and long-term therapeutic value fundamentally changes how I approach patient selection and dosing strategies, pushing me toward more conservative protocols with explicit endpoints rather than open-ended “as needed” prescribing. The evidence gap between patients’ expectations and longitudinal outcomes obligates us to be more transparent about cannabis’s limitations as a standalone [anxiety treatment](https://cedclinic.com/benzodiazepine-discontinuation-rates-medical-cannabis/) and more thoughtful about integrating it with conventional behavioral and pharmacologic interventions. Clinical Perspective Clinical Perspective Recent longitudinal evidence suggesting that regular [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) may not provide sustained [anxiety relief](https://cedclinic.com/cannabis-based-medicine-ptsd-anxiety-relief/) represents an important refinement to our understanding of cannabinoid therapeutics. This finding warrants reconsideration of cannabis as a first-line or maintenance strategy for [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/), particularly given the risk of symptom escalation or dependence with chronic use. Clinicians should continue to emphasize evidence-based interventions such as cognitive-behavioral therapy and, when pharmacologically indicated, medications with established efficacy in [anxiety management](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/). AnxietyCannabis UseMental HealthResearchLong-term Effects 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Daily+Digest%3A+Last+24+Hours%3A+Cannabis+and+Anxiety+Risk+in+the+Long+Run+%E2%80%94+March+03%2C+2026+%40drcaplan&url=) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=) [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Daily+Digest%3A+Last+24+Hours%3A+Cannabis+and+Anxiety+Risk+in+the+Long+Run+%E2%80%94+March+03%2C+2026+--+via+%40drcaplan.bsky.social+) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - [Daily Digest: Last 38 Hours: Cannabinoids, Liver Disease, and the Adolescent Brain — March 08, 2026](https://cedclinic.com/cannabinoid-drug-delivery-breakthroughs-march-2026/) - [In the Mix: 20 More Articles — March 08, 2026](https://cedclinic.com/cannabis-pediatric-exposure-toxicity-march-08-2026/) - [Daily Digest: Last 24 Hours: Cannabinoids and Liver Disease Lead a Research-Heavy Cycle — March 08, 2026](https://cedclinic.com/cbd-cbg-fatty-liver-disease-research-march-2026/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Daily Digest: Last 24 Hours: Cannabinoids and Liver Disease Lead a Research-Heavy Cycle — March 08, 2026](https://cedclinic.com/cbd-cbg-fatty-liver-disease-research-march-2026/) Explore the latest research on cannabinoids and liver disease, highlighting important clinical findings and implications. [Read the Research](https://cedclinic.com/cbd-cbg-fatty-liver-disease-research-march-2026/) [Study explains whether drinking alcohol or smoking weed does more long term damage](https://cedclinic.com/long-term-health-consequences-alcohol-cannabis/) A comparative study analyzing the long-term damage of alcohol versus cannabis use, providing valuable insights for patients and clinicians. [Learn More](https://cedclinic.com/long-term-health-consequences-alcohol-cannabis/) [Cannabis use, anxiety and depression are all on the rise in Canada: study – CTV News](https://cedclinic.com/cannabis-use-mental-health-risks-canada-study/) A recent study highlighting the rising trends of cannabis use alongside anxiety and depression in Canada, with clinical implications. [Explore the Study](https://cedclinic.com/cannabis-use-mental-health-risks-canada-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).